Immunosuppressive Agents: all 5,940 studies that test it
Page 7 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast CancerRecruitingNCT03926091Phase 3
- Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity ConditioningRecruitingNCT03852407Phase 2
- Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological MalignanciesRecruitingNCT03818334Phase 2/3
- CIRTEN-Simultaneous Pancreas-Kidney Transplant RecipientsRecruitingNCT03769298Phase 2/3
- A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell LymphomaRecruitingNCT03758989Phase 2
- Intravitreal Methotrexate and R2(Rituximab & Lenalidomide) Regimen in Newly-diagnosed Primary Vitreoretinal LymphomaRecruitingNCT03746223Phase 2
- STep-up and Step-down Therapeutic Strategies in Childhood ARthritiSRecruitingNCT03728478Phase 3
- Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/LymphomaRecruitingNCT03719105Early Phase 1
- Immunotherapy for the Treatment of Advanced Solid TumorRecruitingNCT03658785Phase 1/2
- PPI Versus Histamine Antagnists as Adjuvant to ChemotherapyRecruitingNCT03647072Phase 3
- Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017RecruitingNCT03643276Phase 3
- Autologous Stem Cell Transplantation in Patients With Systemic SclerosisRecruitingNCT03630211Phase 2
- Adjunctive Treatment for Chronic Rhinosinusitis With Nasal PolyposisNot yet recruitingNCT03607175Phase 2/3
- Cardiac Sarcoidosis Randomized TrialRecruitingNCT03593759Phase 3
- Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell DiseaseRecruitingNCT03587272Phase 2
- Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid LeukemiaRecruitingNCT03586609Phase 2
- Alpha/Beta TCD HCT in Patients With Inherited BMF DisordersRecruitingNCT03579875Phase 2
- [CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS LymphomaRecruitingNCT03569995Phase 2
- Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD ProphylaxisRecruitingNCT03520647Phase 2
- Signal TrAnsduction Pathway Activity Analysis in OVarian cancERRecruitingNCT03458221Phase 2/3
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseRecruitingNCT03414502Phase 3
- Anti T-lymphocyte Immunoglobulin With Post Transplant Cyclophosphamide to Prevent GVHD Post Allogeneic TransplantationRecruitingNCT03357159Phase 2
- Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic ProfileRecruitingNCT03321656Phase 2/3
- GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With NeuroblastomaRecruitingNCT03294954Phase 1
- The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant RecipientsEnrolling by invitationNCT03292861Phase 2
- Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic LeukemiaRecruitingNCT03263572Phase 2
- Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic MalformationsRecruitingNCT03243019Phase 2
- Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate RespondersRecruitingNCT03227419Phase 4
- A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.RecruitingNCT03219450Phase 1
- Autologous Stem Cell Transplant for Crohn's DiseaseRecruitingNCT03219359Phase 2
- A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver TransplantRecruitingNCT03216447Phase 4
- Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling DonorRecruitingNCT03214354Phase 2
- IMPACT Study: IMProve Pregnancy in APS With Certolizumab TherapyRecruitingNCT03152058Phase 2
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/LeukemiaRecruitingNCT03136146Phase 2
- 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute LeukemiaRecruitingNCT03128034Phase 1/2
- Auto Stem Cell Transplant for Lymphoma PatientsRecruitingNCT03125642Phase 2
- Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell DiseaseRecruitingNCT03121001Phase 2
- Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid CancerRecruitingNCT03099356Phase 2
- A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or LymphomaRecruitingNCT03017820Phase 1
- A Randomized Multicenter Study for Isolated Skin VasculitisRecruitingNCT02939573Phase 2
- A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of BreastRecruitingNCT02897700Phase 1
- Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing CancersRecruitingNCT02830724Phase 1/2
- Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic AnemiaRecruitingNCT02828592Phase 2
- European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory TumorsRecruitingNCT02813135Phase 1/2
- Personalized NK Cell Therapy in CBTRecruitingNCT02727803Phase 2
- Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard CareRecruitingNCT02638389Phase 3
- Neoadjuvant Chemotherapy With or Without Huaier Granule in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By SurgeryRecruitingNCT02627248Phase 4
- Phase I/II Trial of Everolimus in Combination With Lonafarnib in ProgeriaEnrolling by invitationNCT02579044Phase 1/2
- Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of RecurrenceRecruitingNCT02446431Early Phase 1
- Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal MetastasisRecruitingNCT02422641Phase 2
- Vascularized Composite Allotransplantation for Treatment of Abdominal Wall DefectsRecruitingNCT02416674Early Phase 1
- Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CRRecruitingNCT02416388Phase 2/3
- Human Penile AllotransplantationRecruitingNCT02395497Phase 2/3
- Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss TherapyRecruitingNCT02310867Phase 2
- Effects of Treatment With Biological Agents on Vascular and Cardiac Function in PsoriasisRecruitingNCT02144857Phase 4
- HSCT for Patients With Fanconi Anemia Using Risk-Adjusted ChemotherapyRecruitingNCT02143830Phase 2
- T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung CancerRecruitingNCT02133196Phase 2
- Therapy Optimisation for the Treatment of Hairy Cell LeukemiaRecruitingNCT02131753Phase 2/3
- Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid LeukemiaRecruitingNCT02115295Phase 2
- Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver CancerEnrolling by invitationNCT02081755Phase 4
- Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous MalformationsRecruitingNCT02042326Phase 2
- Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatmentRecruitingNCT02029001Phase 2
- Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative StudyRecruitingNCT02025023Phase 3
- Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid TumorsRecruitingNCT02013336Phase 1
- Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic LeukaemiaRecruitingNCT01949129Phase 2/3
- Allogeneic Hematopoietic Stem Cell Transplant for GATA2 MutationsRecruitingNCT01861106Phase 2
- Reduced Intensity Haploidentical BMT for High Risk Solid TumorsRecruitingNCT01804634Phase 2
- High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)RecruitingNCT01704716Phase 3
- Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic SyndromeRecruitingNCT01624805Phase 2
- Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)RecruitingNCT01515527Phase 2
- Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical DonorsRecruitingNCT01374841Phase 2
- Rituximab Plus Cyclosporine in Idiopathic Membranous NephropathyRecruitingNCT00977977Phase 2
- Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeRecruitingNCT00801489Phase 2
- Cladribine and Rituximab in Treating Patients With Hairy Cell LeukemiaRecruitingNCT00412594Phase 2
- A Study to Assess the Concentration of Rozanolixizumab in the Breast Milk of Healthy Lactating WomenCompletedNCT06720714Phase 1Results posted
- Comparison of Efficacy of Methotrexate and Azathioprine in Patients With Chronic Actinic Dermatitis: A Randomized Controlled TrialCompletedNCT06476366Early Phase 1Results posted
- A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With CyclosporineCompletedNCT06329661Phase 4Results posted
- A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory GoutCompletedNCT06229145Phase 4Results posted
- HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCLCompletedNCT06149247Phase 2Results posted
- Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ FunctionActive, not recruitingNCT06145282Phase 1/2Results posted
- Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell LiposarcomaCompletedNCT05993299Phase 2Results posted
- Subcutaneous Abatacept in Renal Transplant RecipientsCompletedNCT05975450Phase 1Results posted
- Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP StudyTerminatedNCT05960578Phase 2Results posted
- A Study of Belimumab in Chinese Pediatric Participants With Systemic Lupus ErythematosusCompletedNCT05917288Phase 1Results posted
- Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy TrialCompletedNCT05822583Phase 4Results posted
- Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell TherapyTerminatedNCT05714345Phase 2Results posted
- A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)CompletedNCT05681715Phase 3Results posted
- A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)Active, not recruitingNCT05673785Phase 2Results posted
- Premedication to Reduce Amivantamab Associated Infusion Related ReactionsActive, not recruitingNCT05663866Phase 2Results posted
- A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participants With Severe Fibromyalgia SyndromeCompletedNCT05643794Phase 2Results posted
- Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.TerminatedNCT05579769Phase 2Results posted
- Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular EdemaCompletedNCT05512962Phase 2Results posted
- Trial Comparing Three Single Dose Injections for Knee OsteoarthritisTerminatedNCT05492851Phase 4Results posted
- Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin AnalysisCompletedNCT05436535Phase 4Results posted
- A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula SurgeryCompletedNCT05425056Phase 3Results posted
- A Study in Subjects With Retinitis PigmentosaCompletedNCT05392179Phase 2Results posted
- PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell LymphomaCompletedNCT05380635Phase 2Results posted
- Sirolimus for Nosebleeds in HHTCompletedNCT05269849Phase 2Results posted
- Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19TerminatedNCT05166876Phase 2Results posted
- Off-the-shelf NK Cells + SCT for Myeloid MalignanciesCompletedNCT05115630Phase 2Results posted